Effects of Angiotensin-Converting Enzyme Inhibitor Versus Valsartan on Cellular Signaling Events in Heart Transplant
Michel White(Montreal Heart Institute), Laure Voisin(Institute for Research in Immunology and Cancer), Normand Racine(Montreal Heart Institute), Lucette Whittom(Montreal Heart Institute), Sylvain Meloche(Institute for Research in Immunology and Cancer), Guy Pelletier(Alberta Health Services), Sylvie Lévesque, Heather J. Ross(University of Toronto)
Cited by 2
Related Papers
Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction
|Circulation|2003|581
Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring
|Circulation|2019|570
F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction and Suspected Coronary Disease
|Journal of the American College of Cardiology|2007|476
A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial
|Journal of the American College of Cardiology|1999|385
Mobile Phone-Based Telemonitoring for Heart Failure Management: A Randomized Controlled Trial
|Journal of Medical Internet Research|2012|369